Insider Transactions in Q4 2021 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 28
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,764
-0.01%
|
$22,112
$8.51 P/Share
|
Dec 27
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
600
-0.0%
|
$4,800
$8.56 P/Share
|
Dec 23
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
81,187
-0.34%
|
$649,496
$8.55 P/Share
|
Dec 09
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
23,660
-0.1%
|
$189,280
$8.56 P/Share
|
Dec 08
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
75,814
-0.31%
|
$606,512
$8.64 P/Share
|
Dec 07
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
52,178
-0.21%
|
$417,424
$8.52 P/Share
|
Dec 02
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,874
-0.01%
|
$14,992
$8.51 P/Share
|
Dec 01
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
730
-0.0%
|
$5,840
$8.52 P/Share
|
Nov 26
2021
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,884
-0.12%
|
$231,072
$8.6 P/Share
|
Oct 29
2021
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
140
-0.26%
|
$1,120
$8.12 P/Share
|